Last reviewed · How we verify

NCT05171738

Distalization Via Skeletally-anchored Distaljet Appliance With Two Approaches of Micro-osteoperforations

Status unknown NA Last updated 25 April 2022
What this trial tests

NA trial testing skeletally anchored distal jet in Class II Division 1 Malocclusion in 20 participants. Status unknown.

Timeline
1 September 2021
Primary endpoint
1 October 2023
1 November 2023

Quick facts

Lead sponsorAl-Azhar University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment20
Start date1 September 2021
Primary completion1 October 2023
Estimated completion1 November 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Al-Azhar University

Who can join

Adults 13 to 17, any sex, with Class II Division 1 Malocclusion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

study will be directed to evaluate two approaches of micro-osteoperforations during maxillary molar distalization.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Pain Intensity of Skeletally Anchored Maxillary Molar Distalization in Conjunction with Micro-osteoperforations: A Randomized Clinical Trial
    Mohammed Bahaa El-Din A, Abd El Khaliq Hendy K, Elghetany Mohamed R, Abouelnour A, et al ·

Verify or expand the search:

Other Al-Azhar University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05171738.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing